InsidersTradesSigma
Track the Laurus Labs Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Laurus Labs Limited has recorded 94 reports. Market capitalisation: €962.5bn. The latest transaction was disclosed on 6 December 2024 (Pledge). Among the most active insiders: NURUBHASHA BABCHAND. The full history is accessible without an account.
94
Insider Decl.
n/a
Thresholds
€230,889
9 ops.
Buy Volume
€11m
63 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Laurus Labs Limited Hold (neutral), based on 14 analysts. Average price target: ₹1,486.29.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,316 of 29,062 companies
50.5
score / 100
Value27
Quality74
FCF yld0.6%
Earn yld0.9%
EV/EBITDA54.2x
ROE18%
Gross mgn59%
Net mgn13%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 December 2024
Declarations94 total
200,000 shares@ ₹576.4053.2% of flowEquity SharesSEBI:f056e113b6d76c2ca2150ffbc16b0d83f54e802b
10,000 shares@ ₹376.00100.0% of flowEquity SharesSEBI:65a5ebe59fea5b64a320934230be0c60f5938025
3,992 shares@ ₹578.699951.9% of flowEquity SharesSEBI:533ed4ab7f20b74154ba14b1ace39f1f40980e44
2,906 shares@ ₹578.699937.9% of flowEquity SharesSEBI:f42d38f3df2b5437d430c3531e677c3a8b4b41c6
788 shares@ ₹578.700510.2% of flowEquity SharesSEBI:3366fdec688fd4954445e2ed651c1ee188c066c3
2,275 shares@ ₹525.9451100.0% of flowEquity SharesSEBI:9918aa918bf48f376276e65749d72798b1cc2fd3
10,000 shares@ ₹539.6671100.0% of flowEquity SharesSEBI:38648633ccebbcc5b348287b244fdaf2237aa5f6
10,245 shares@ ₹505.00100.0% of flowEquity SharesSEBI:3c64216c2911c4481747e64cfffb129684c055bf
12,000 shares@ ₹657.9167100.0% of flowEquity SharesSEBI:89cce66f57a00d5b944c713995d2af8d7b6e43a9
1,000 shares@ ₹650.007.8% of flowEquity SharesSEBI:70dd415dbf1f2fff1e417e60f5b64c1724e22ace
4,000 shares@ ₹650.9031.8% of flowEquity SharesSEBI:38a73e3679e9a0368c34fa465ac3b651400cd155
5,500 shares@ ₹657.000.0000% mcap100.0% of flowEquity SharesSEBI:3b480afbc23a058629b405c641fa3064b07d5c5c
3,000 shares@ ₹669.76430.0000% mcap100.0% of flowEquity SharesSEBI:69648c1b026d439e29642d979c59be7d7a2381e4
18,120 shares@ ₹703.27230.0000% mcap4.9% of flowEquity SharesSEBI:47edc5b96d5919ef4a2dcb5a7d387403d19e4e4c
20,000 shares@ ₹700.000.0000% mcap5.3% of flowEquity SharesSEBI:b764e1f7fab1b1c9f44ecd5b7252fd53243b16b9
67,657 shares@ ₹702.89240.0002% mcap18.2% of flowEquity SharesSEBI:8679313bcf167fe661ae23babba4951a458450ed
1,445 shares@ ₹700.99930.0000% mcap50.1% of flowEquity SharesSEBI:ff4d7d5e25c0c2d0470fdb1a36453dbb2b20936d
2,910 shares@ ₹688.65020.0000% mcap36.5% of flowEquity SharesSEBI:d7094110df1c126fb2f2988a96abed8cbf40527c
5,060 shares@ ₹688.650.0000% mcap63.5% of flowEquity SharesSEBI:d841479378fac38ef620176828126f861f5e726f
20,000 shares@ ₹686.000.0000% mcap50.0% of flowEquity SharesSEBI:db9fb14bf57d4a899c78847d77441a2534d75dca
6,500 shares@ ₹688.75150.0000% mcap89.0% of flowEquity SharesSEBI:bca8cc04a27c9c9810a2152f45418010ba142aa3
15,000 shares@ ₹687.33330.0000% mcap100.0% of flowEquity SharesSEBI:c1c3cddf953e72821edf1b79140eee6568300dff
100,000 shares@ ₹683.000.0002% mcap68.8% of flowEquity SharesSEBI:cca0346f49eb11a88e6d509fba87315a476c63c6
1,500 shares@ ₹466.170.0000% mcap11.0% of flowEquity SharesSEBI:3416b6b38ae404ebeaeeebb5147776a5a23dd514
25 of 94 declarations
About Laurus Labs Limited
Laurus Labs Limited is an Indian pharmaceutical company engaged in the research, development, and manufacturing of generic pharmaceutical products. It primarily focuses on antiretroviral drugs and healthcare products.